News related to Remicade (Infliximab) and/or conditions it is approved for
Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.
Remsima (infliximab) accepted for restricted use in NHS Scotland by the Scottish Medicines Consortium
Source: Arthritis / Rheumatology News From Medical News Today [2015.03.11]
Patients in Scotland suffering from inflammatory conditions including rheumatoid arthritis (RA), Crohn's Disease (CD), ulcerative colitis (UC), and psoriasis will now have access to a new wave of...